Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy

Wilentz, 1998, Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression, Cancer Res, 58, 4740

Wilentz, 2000, Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression, Cancer Res, 60, 2002

Goggins, 2000, BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications, Am J Pathol, 156, 1767, 10.1016/S0002-9440(10)65047-X

Ueno, 2009, A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese study group of adjuvant therapy for pancreatic cancer, Br J Cancer, 101, 908, 10.1038/sj.bjc.6605256

Nimura, 2012, Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial, J Hepatobiliary Pancreat Sci, 19, 230, 10.1007/s00534-011-0466-6

Oettle, 2013, Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial, JAMA, 310, 1473, 10.1001/jama.2013.279201

Dalla Valle, 2006, Pancreatic carcinoma recurrence in the remnant pancreas after a pancreaticoduodenectomy, JOP, 7, 473

Naito, 2009, Multi-centric pancreatic cancer without PanIN lesion, J Hepatobiliary Pancreat Surg, 16, 699, 10.1007/s00534-009-0065-y

Ogino, 2010, Repeated pancreatectomy for recurrent pancreatic carcinoma after pylorus-preserving pancreatoduodenectomy: report of two patients, Case Rep Gastroenterol, 4, 429, 10.1159/000321513

Koizumi, 2010, Remnant pancreatectomy for recurrent or metachronous pancreatic carcinoma detected by FDG-PET: two case reports, JOP, 11, 36

Ikematsu, 2011, Metachronous multiple adenocarcinomas of the pancreas, Int J Clin Oncol, 16, 726, 10.1007/s10147-011-0206-6

Akabori, 2014, Resectable carcinoma developing in the remnant pancreas 7 years and 10 months after distal pancreatectomy for invasive ductal carcinoma of the pancreas: report of a case, World J Surg Oncol, 12, 224, 10.1186/1477-7819-12-224

Kleeff, 2007, Surgery for recurrent pancreatic ductal adenocarcinoma, Ann Surg, 245, 566, 10.1097/01.sla.0000245845.06772.7d

Lavu, 2011, Reoperative completion pancreatectomy for suspected malignant disease of the pancreas, J Surg Res, 170, 89, 10.1016/j.jss.2011.04.050

Miyazaki, 2014, Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?, Surgery, 155, 58, 10.1016/j.surg.2013.06.050

Hashimoto, 2014, Pancreatic cancer in the remnant pancreas following primary pancreatic resection, Surg Today, 44, 1313, 10.1007/s00595-013-0708-0

Shima, 2015, Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of the literature, Langenbecks Arch Surg, 400, 973, 10.1007/s00423-015-1355-2

Ikeda, 2005, Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer, Br J Surg, 92, 235, 10.1002/bjs.4758

Nozaki, 2010, Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery, World J Surg, 34, 1548, 10.1007/s00268-010-0518-0

Nozaki, 2014, Incidence of metachronous gastric cancer in the remnant stomach after synchronous multiple cancer surgery, Gastric Cancer, 17, 61, 10.1007/s10120-013-0261-y

2015

Canto, 2012, Frequent detection of pancreatic lesions in asymptomatic high-risk individuals, Gastroenterology, 142, 796, 10.1053/j.gastro.2012.01.005

Harinck, 2015, A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals, Gut

Watanabe, 2015, Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life, World J Surg, 39, 1231, 10.1007/s00268-015-2948-1

Zounkova, 2010, Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites, Chemosphere, 81, 253, 10.1016/j.chemosphere.2010.06.029

Kristinsson, 2014, Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up, Haematologica, 99, 392, 10.3324/haematol.2013.092460

Kitagawa, 2013, The retropancreatic fusion fascia acts as a barrier against infiltration by pancreatic carcinoma, Mol Clin Oncol, 1, 418, 10.3892/mco.2013.98

Loe, 2013, Pancreatic cancer: modulation of KRAS, microRNAs, and intercellular communication in the setting of tumor heterogeneity, Pancreas, 42, 1218, 10.1097/MPA.0000000000000007